Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Squamous Cell Carcinoma × Lapatinib × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasms 13 Neoplasm Metastasis 6 Breast Neoplasms, Male 6 Brain Neoplasms 6 Head and Neck Neoplasms 5 Ovarian Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteitis Deformans 2 Neuroma, Acoustic 2 Neurofibromatosis 2 2 Inflammatory Breast Neoplasms 2 Esophageal Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Intraductal, Noninfiltrating 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1

Interventions

Radiotherapy 10 Cisplatin 9 Paclitaxel 8 pembrolizumab 7 Fluorouracil 7 Oxaliplatin 6 Irinotecan 6 Cetuximab 5 tislelizumab 4 Docetaxel 4 Radiation 3 Leucovorin 3 Carboplatin 3 Capecitabine 3 Nivolumab 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Biopsy 2 10-propargyl-10-deazaaminopterin 2 tremelimumab 1 sitravatinib 1 sintilimab 1 regorafenib 1 pegylated granulocyte colony-stimulating factor, human 1 pegfilgrastim 1 oblimersen 1 durvalumab 1 cixutumumab 1 adavosertib 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡